JANUS ASSOCIATED KINASES INHIBITORS IN THE PHARMACOLOGICAL THERAPEUTIC
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: SANTOS, Daniela (University of Beira Interior, Health Science Faculty, Covilhã, Portugal)
- Co-author(s): Ema Paulino
Janus Associated Kinases (JAK) inhibitors have proved to be promising in the treatment of arthritis, psoriasis, organ rejection and multiple cancer types. However, major adverse drug reactions (ADR) are associated to these drugs, which require close monitoring by healthcare professionals.
Literature review of Summary of Product Characteristics of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.